Rebecca Hoh

Rebecca Hoh

UNVERIFIED PROFILE

Are you Rebecca Hoh?   Register this Author

Register author
Rebecca Hoh

Rebecca Hoh

Publications by authors named "Rebecca Hoh"

Are you Rebecca Hoh?   Register this Author

75Publications

1708Reads

7Profile Views

Reiterative Enrichment and Authentication of CRISPRi Targets (REACT) identifies the proteasome as a key contributor to HIV-1 latency.

PLoS Pathog 2019 01 15;15(1):e1007498. Epub 2019 Jan 15.

Department of Molecular and Cell Biology, University of California, Berkeley, California, United States of America.

View Article

Download full-text PDF

Source
http://dx.plos.org/10.1371/journal.ppat.1007498
Publisher Site
http://dx.doi.org/10.1371/journal.ppat.1007498DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333332PMC
January 2019

Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study.

Lancet HIV 2015 Dec 17;2(12):e520-9. Epub 2015 Nov 17.

Department of Infectious Diseases, Monash University and Alfred Hospital, Melbourne, VIC, Australia; The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://www.thelancet.com/pdfs/journals/lanhiv/PIIS2352-3018(
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S235230181500226
Publisher Site
http://dx.doi.org/10.1016/S2352-3018(15)00226-XDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108570PMC
December 2015

Composition and function of T cell subpopulations are slow to change despite effective antiretroviral treatment of HIV disease.

PLoS One 2014 21;9(1):e85613. Epub 2014 Jan 21.

Positive Health Program, University of California San Francisco, San Francisco, California, United States of America ; Division of Experimental Medicine, University of California San Francisco, San Francisco, California, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0085613PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897457PMC
October 2014

Comparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollers.

AIDS 2013 Sep;27(14):2255-60

aDepartment of Medicine bDepartment of Epidemiology and Biostatistics, University of California cSan Francisco Veterans Affairs Medical Center, San Francisco, California, USA.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/QAD.0b013e328362692fDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143147PMC
September 2013

HIV disease progression correlates with the generation of dysfunctional naive CD8(low) T cells.

Blood 2011 Feb 3;117(7):2189-99. Epub 2011 Jan 3.

Division of Experimental Medicine, University of California at San Francisco, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-06-288035DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062328PMC
February 2011

Viral dynamics and in vivo fitness of HIV-1 in the presence and absence of enfuvirtide.

J Acquir Immune Defic Syndr 2008 Aug;48(5):572-6

Section of Retroviral Therapeutics, Brigham and Women's Hospital and Division of AIDS, Harvard Medical School, Boston, MA 02139, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0b013e31817bbc4eDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2709806PMC
August 2008

Continued evolution in gp41 after interruption of enfuvirtide in subjects with advanced HIV type 1 disease.

AIDS Res Hum Retroviruses 2006 Dec;22(12):1260-6

Department of Biostatistics, University of California, Los Angeles, Los Angeles, California 90095, Section of Retroviral Therapeutics, Brigham and Women's Hospital, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://www.liebertpub.com/doi/10.1089/aid.2006.22.1260
Publisher Site
http://dx.doi.org/10.1089/aid.2006.22.1260DOI Listing
December 2006

Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremia.

J Infect Dis 2006 Oct 29;194(7):926-30. Epub 2006 Aug 29.

Positive Health Program, San Francisco General Hospital, San Francisco, CA 94110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/507312DOI Listing
October 2006

Rapid emergence of enfuvirtide resistance in HIV-1-infected patients: results of a clonal analysis.

J Acquir Immune Defic Syndr 2006 Sep;43(1):60-4

Section of Retroviral Therapeutics, Brigham and Women's Hospital, and Division of AIDS, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00126334-200609000-000
Publisher Site
http://dx.doi.org/10.1097/01.qai.0000234083.34161.55DOI Listing
September 2006

The independent effect of drug resistance on T cell activation in HIV infection.

AIDS 2006 Mar;20(5):691-9

Positive Health Program, San Francisco General Hospital, University of California, San Francisco, California 94110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.aids.0000216369.30948.18DOI Listing
March 2006

Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infection.

J Infect Dis 2005 Nov 20;192(9):1537-44. Epub 2005 Sep 20.

University of California, San Francisco, and San Francisco General Hospital, San Francisco 94110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/496892DOI Listing
November 2005

Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection.

J Clin Invest 2003 Sep;112(6):956-66

University of California, Berkeley, 119 Morgan Hall, Berkeley, California 94720-3104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI17533DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC193663PMC
September 2003

Persistence of drug-resistant HIV-1 after a structured treatment interruption and its impact on treatment response.

AIDS 2003 Feb;17(3):361-70

University of California-San Francisco and San Francisco General Hospital, 995 Potrero Avenue, San Francisco, CA 94110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00002030-200302140-00010DOI Listing
February 2003

CD4+ T cell kinetics and activation in human immunodeficiency virus-infected patients who remain viremic despite long-term treatment with protease inhibitor-based therapy.

J Infect Dis 2002 Feb 17;185(3):315-23. Epub 2002 Jan 17.

Department of Medicine, University of California at San Francisco and San Francisco General Hospital, San Francisco, CA 94110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/338467DOI Listing
February 2002